Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Labcorp Holdings Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fortrea Holdings Inc. June 9, 202692.2%
-
Labcorp Holdings Inc. May 21, 202693.5%
-
Labcorp Holdings Inc. May 15, 202595.3%
-
Labcorp Holdings Inc. May 11, 202397.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Adaptive Biotechnologies Corporation | Option exercise | +15,000 | $6.32 | $94,800 |
| Aug 17, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −15,000 | $25.23 | $378,450 |
| Aug 17, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −40,000 | $25.10 | $1,004,000 |
| Aug 17, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −69,690 | $25.16 | $1,753,400 |
| May 14, 2026 | Fortrea Holdings Inc. | Option exercise | +148,536 | — | — |
| Mar 4, 2026 | Adaptive Biotechnologies Corporation | Grant or award | +15,625 | — | — |
| Feb 11, 2026 | Labcorp Holdings Inc. | Option exercise | +897 | — | — |
| Aug 11, 2025 | Fortrea Holdings Inc. | Open-market purchase | +32,500 | $6.26 | $203,450 |
| Aug 8, 2025 | Fortrea Holdings Inc. | Open-market purchase | +30,000 | $6.79 | $203,700 |
| May 14, 2025 | Fortrea Holdings Inc. | Option exercise | +7,282 | — | — |
| Mar 10, 2025 | Adaptive Biotechnologies Corporation | Option exercise | +50,000 | $4.07 | $203,500 |
| Mar 10, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −10,000 | $7.05 | $70,500 |
| Mar 4, 2025 | Adaptive Biotechnologies Corporation | Grant or award | +15,394 | — | — |
| Feb 6, 2025 | Labcorp Holdings Inc. | Option exercise | +944 | — | — |
| Jul 18, 2024 | Fortrea Holdings Inc. | Option exercise | +6,354 | — | — |
Questions about Peter M. Neupert
What boards is Peter M. Neupert on?
Peter M. Neupert sits on the boards of Adaptive Biotechnologies Corporation, Fortrea Holdings Inc. and Labcorp Holdings Inc.
Has Peter M. Neupert been a CEO?
Yes — Peter M. Neupert was CEO of Fortrea Holdings Inc. (Until August 2025).
How long has Peter M. Neupert served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.